A collage photo of Christine Lovly and Misty Dawn Shields
May 16, 2024, 10:23
News and Views from Christine Lovly and Misty Dawn Shields – Nature Medicine
Nature Medicine shared on X:
“Refining neoadjuvant immunotherapy for resectable Non- Small Cell Lung Cancer (NSCLC):
Perioperative approaches are expanding, and new data show feasibility of co-targeting PD-1 and LAG-3.
News and Views from Christine Lovly, Misty Dawn Shields and Vanderbilt University Medical Center.”
Additional information.
Source: Nature Medicine/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29
Dec 21, 2024, 08:12
Dec 21, 2024, 07:45
Dec 21, 2024, 05:54